Illustration of three DNA helices

Asklepios BioPharmaceutical

Taking the No. 3 and No. 4 spots with back-to-back rounds is Asklepios BioPharmaceutical, which is working on adeno-associated virus gene therapies across neuromuscular, central nervous system and heart diseases.